Audrey Vandomme

Audrey Vandomme has worked in the scientific field since 2015. Audrey began their career as a postdoctoral fellowship at The Francis Crick Institute, where they worked on a project exploring the role of the pir gene multifamily in Plasmodium chabaudi chabaudi infection. Audrey developed and adapted the CRISPR technology for Plasmodium chabaudi during this time. In 2019, they moved to PredictImmune as a Senior Scientist. Most recently, in 2021, they joined Cambridge Epigenetix as a Senior Scientist.

Audrey Vandomme obtained their Doctor of Philosophy (PhD) in Parasitology from the University of Lille 1 Sciences and Technology in 2014. Prior to that, they completed their Master's degree in Parasitology and Immunology from the same university in 2010.